NetworkNewsBreaks – MetAlert Inc. (MLRT) Bringin
Post# of 271
MetAlert (OTC: MLRT) is a pioneer in location-sensitive health devices and wearable technology products for remote patient monitoring. The company “has, since inception, sought to offer quality-of-life improvements to patients and consumers who have Alzheimer’s, dementia and autism (‘ADA’)… Its flagship GPS SmartSoles HUB launched in the fourth quarter of the 2022 financial year, allowing for remote monitoring, data collection and encrypted data transmission to the cloud. In addition, RoomMate, MetAlert’s latest offering, allows caregivers to monitor patient behavior that could lead to falls and injuries without invading their privacy. As evidenced by these two products, MetAlert prioritizes patient confidentiality while pushing the needle regarding the use of technology to improve service delivery and the quality of life of patients afflicted with ADA,” a recent article explains. “The focus on this target population has also seen MetAlert offer hearing aids, ranging from its flagship Hear IQ 4 rechargeable, app-controlled hearing aid to the NRBz noise-reducing buds. The company also offers HearingVite, a formulation proven to boost memory and cognitive function among individuals aged 50 years and above. It also offers Ear-Ring Relief, a formula that integrates vitamins, minerals and nutritional supplements to relieve tinnitus sufferers.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer